G. Quéreux

Centre National de la Recherche Scientifique

Also affiliated with Inserm, Centre Hospitalier Universitaire de Nantes, Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers, Centre d'Investigation Clinique de Nantes, Immunologie et Nouveaux Concepts en Immunothérapie, Nantes Université

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients”.

Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients

British Journal of Dermatology(2023)10.1093/bjd/ljad369

N/A

0DataRank · unranked

44 citations

F. Lombart, G. Chaby, A. Dadban, S. Debarbieux, M. Viguier +28 more